Michael William Pride
14Patents
5h-index
21Co-inventors
66Inventor score
Filing activity: Nov 12, 1993 → Jul 15, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9492559B2 | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | Emerging Cross-Sectional Technologies | 36 | Active |
| US6867000B2 | Method of enhancing immune responses to herpes | Chemistry; Metallurgy | 10 | Expired |
| US5531990A | Method of raising an immune response with an anti-idiotypic antibody having correspondence with human hepatitis B surface antigen | Human Necessities | 9 | Expired |
| US10653764B2 | Immunogenic compositions for use in pneumococcal vaccines | Human Necessities | 6 | Active |
| US11090375B2 | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US10786561B2 | Immunogenic compositions for use in pneumococcal vaccines | Human Necessities | 5 | Active |
| US11160855B2 | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US11135279B2 | Immunogenic compositions for use in pneumococcal vaccines | Human Necessities | 2 | Active |
| US11413344B2 | Immunogenic compositions for use in pneumococcal vaccines | Human Necessities | 1 | Active |
| US5744135A | Method of raising an immune response with an anti-idiotypic antibody having correspondence with human hepatitis B surface antigen | Human Necessities | 1 | Expired |
| US6319501A | Method of immunizing against hepatitis B virus | Chemistry; Metallurgy | 1 | Expired |
| US12318438B2 | Immunogenic compositions for use in pneumococcal vaccines | Human Necessities | 0 | Active |
| US5668253A | "Peptide having antigenic properties similar to ""a ""determinant of hepatitis B surface antigen" | Human Necessities | 0 | Expired |
| US11872274B2 | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.